Terran is interested in improving the NK cell response in ovarian cancer, as well as HLA-mediated interactions that result in activation or inhibition of NK cells in cancer. Outside of lab, he can usually be found doing crafts, playing with his niece and nephew, or outside surrounded by nature.

His research projects involve the development and optimization of NK cell engager molecules utilizing a dual target approach. Compared to molecules with a single tumor target, we hope to decrease antigen escape and increase the half life of engager molecules. 

In this setting, he hopes to investigate HLA-mediated interactions and target tumor-associated antigens with functional importance, like CD70, B7H3, and CD133, all of which are overexpressed in ovarian (and other) cancers.